(Q28645842)

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Characteristics of the binding of human C-reactive protein (CRP) to laminin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interaction of C-reactive protein with artificial phosphatidylcholine bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein binding specificities: artificial and natural phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein (CRP) and autoimmune disease: facts and conjectures.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Points of control in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

A calculated response: control of inflammation by the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Serum C-reactive protein levels in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Expression of C-reactive protein in the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The kidney as a second site of human C-reactive protein formation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Systemic effects of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

When do social inequalities in C-reactive protein start? A life course perspective from conception to adulthood in the Cardiovascular Risk in Young Finns Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Effect of alcohol consumption on systemic markers of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Alcohol consumption and plasma concentration of C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Relation of dietary fat and fiber to elevation of C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Distributions of C-reactive Protein Measured by High-Sensitivity Assays in Apparently Healthy Men and Women from Different Populations in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Population Distribution of High-Sensitivity C-reactive Protein among US Men: Findings from National Health and Nutrition Examination Survey 1999-2000

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Social inequality, ethnicity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Ethnic Differences in C-Reactive Protein Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Mediterranean diet, endothelial function and vascular inflammatory markers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The effect of weight loss on C-reactive protein: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Preadipocyte conversion to macrophage. Evidence of plasticity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Association between dietary fiber and serum C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Whole-grain foods, dietary fiber, and type 2 diabetes: searching for a kernel of truth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Dietary fiber, inflammation, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-6: from basic science to medicine--40 years in immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Initiation of acute phase response and synthesis of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Intrapituitary expression and regulation of the gp130 cytokine interleukin-6 and its implication in pituitary physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Hypothalamic-Pituitary Cytokine Network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

CCAAT/enhancer-binding proteins: structure, function and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Blocking IL-1 in systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The role of interleukin-1 in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Intracellular IL-1alpha-binding proteins contribute to biological functions of endogenous IL-1alpha in systemic sclerosis fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Rapid secretion of interleukin-1beta by microvesicle shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The P2X7 receptor: a key player in IL-1 processing and release

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin 1 signaling occurs exclusively via the type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Modulation of Toll-interleukin 1 receptor mediated signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Role of interleukin-6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1 β and interleukin-6 in the human hepatoma cell line PLC/PRF/5

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

IL-1, IL-18, and IL-33 families of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-17 family and IL-17 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated prot

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Binding of C/EBPbeta to the C-reactive protein (CRP) promoter in Hep3B cells is associated with transcription of CRP mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

beta-Thymosins are not simple actin monomer buffering proteins. Insights from overexpression studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein levels are influenced by common IL-1 gene variations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1β and C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Effects of the Interaction between Interleukin-6 -634C/G Polymorphism and Smoking on Serum C-Reactive Protein Concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

The TNF-α G-308A polymorphism is associated with C-reactive protein levels: The HERITAGE Family Study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948005-3

7 January 2021